SummaryPrimary osteoarthritis (OA) is associated with aging, while postâtraumatic OA (PTOA) is associated with mechanical injury and inflammation. It is not clear whether the two types of osteoarthritis share common mechanisms. We found that miRâ146a, a microRNAâassociated with inflammation, is activated by cyclic load in the physiological range but suppressed by mechanical overload in human articular chondrocytes. Furthermore, miRâ146a expression is decreased in the OA lesions of human articular cartilage. To understand the role of miRâ146a in osteoarthritis, we systemically characterized mice in which miRâ146a is either deficient in whole body or overexpressed in chondrogenic cells specifically. miRâ146aâdeficient mice develop early onset of OA characterized by cartilage degeneration, synovitis, and osteophytes. Conversely, miRâ146a chondrogenic overexpressing mice are resistant to agingâassociated OA. Loss of miRâ146a exacerbates articular cartilage degeneration during PTOA, while chondrogenic overexpression of miRâ146a inhibits PTOA. Thus, miRâ146a inhibits both OA and PTOA in mice, suggesting a common protective mechanism initiated by miRâ146a. miRâ146a suppresses ILâ1ÎČ of catabolic factors, and we provide evidence that miRâ146a directly inhibits Notch1 expression. Therefore, such inhibition of Notch1 may explain suppression of inflammatory mediators by miRâ146a. Chondrogenic overexpression of miRâ146a or intraâarticular administration of a Notch1 inhibitor alleviates ILâ1ÎČâinduced catabolism and rescues joint degeneration in miRâ146aâdeficient mice, suggesting that miRâ146a is sufficient to protect OA pathogenesis by inhibiting Notch signaling in the joint. Thus, miRâ146a may be used to counter both agingâassociated OA and mechanical injuryâ/inflammationâinduced PTOA.